Low eukaryotic viral richness is associated with faecal microbiota transplantation success in patients with UC

Gut

Volumn 67, Issue 8, 2018, Pages 1558-1559

  Conceição Neto, Nádia ^a   Deboutte, Ward ^a   Dierckx, Tim ^a   Machiels, Kathleen ^b   Wang, Jun ^a,c   Yinda, Kwe Claude ^a   Maes, Piet ^a   Van Ranst, Marc ^a   Joossens, Marie ^a,c   Raes, Jeroen ^a,c   Vermeire, Séverine ^b   Matthijnssens, Jelle ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

intestinal microbiology; ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER; DNA; RNA;

CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; CORRELATIONAL STUDY; EUKARYOTE; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; GENOME; HUMAN; LETTER; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPECIES RICHNESS; THERAPY EFFECT; TREATMENT RESPONSE; VIRUS; VIRUS CELL INTERACTION; FECES; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; EUKARYOTA; FECAL MICROBIOTA TRANSPLANTATION; FECES; HUMANS;

EID: 85043304296     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2017-315281     Document Type: Letter

References (9)

1. Zuo T, Wong SH, Lam K, et al. Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome. Gut 2018;67:634-43.
2. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368:407-15.
3. Austin M, Mellow M, Tierney WM. Fecal microbiota transplantation in the treatment of Clostridium difficile infections. Am J Med 2014;127:479-83.
4. Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017;66:569-80.
5. Vermeire S, Joossens M, Verbeke K, et al. Donor species richness determines faecal microbiota transplantation success in inflammatory Bowel disease. J Crohns Colitis 2016;10:387-94.
6. Conceição-Neto N, Zeller M, Lefrère H, et al. Modular approach to customise sample preparation procedures for viral metagenomics: A reproducible protocol for virome analysis. Sci Rep 2015;5:16532.
7. Norman JM, et al. Disease-specific alterations in the enteric Virome in article disease-specific alterations in the enteric Virome in inflammatory Bowel disease. Cell 2015;160:447-60.
8. Angelberger S, Reinisch W, Makristathis A, et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013;108:1620-30.
9. Koonin EV, Dolja VV, Krupovic M. Origins and evolution of viruses of eukaryotes: The ultimate modularity. Virology 2015;479:2-25.